The PE ratio for Resmed stock stands at 30.22 as of Jul 26, 2024. This is calculated based on the TTM EPS of $6.52 and the stock price of $197.04 per share. An increase of 2.1% has been observed in the PE ratio compared to its average of 29.6 of the last four quarters.
Over the last ten years, the average PE ratio of Resmed has been 38.25. The current 30.22 P/E ratio is 21% lower than the historical average. Looking back at the last ten years, RMD's PE ratio peaked in the Sep 2021 quarter at 76.39, with a price of $263.55 and an EPS of $3.45. The Sep 2014 quarter marked the lowest point at 20.03, with a price of $49.27 and an EPS of $2.46.
Maximum annual increase: 69.23% in 2021
Maximum annual decrease: -47.92% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 35.7 | -9.07% |
| 2022 | 39.26 | -47.92% |
| 2021 | 75.39 | 69.23% |
| 2020 | 44.55 | 3.32% |
| 2019 | 43.12 | -8% |
| 2018 | 46.87 | 45.65% |
| 2017 | 32.18 | 27.75% |
| 2016 | 25.19 | 12.15% |
| 2015 | 22.46 | 8.24% |
| 2014 | 20.75 | -1.14% |
Currently, RMD's PE ratio is lower than its 3, 5 and 10-year averages.
RMD's PE ratio stands lower than its peer stocks TMO and MASI, but it is higher than MDT's and ELMD's. Resmed's current PE ratio of 30.22 is lower than the average of its peers, which is 42.46.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MDT Medtronic plc | 28.41 | $100.91B |
| ELMD Electromed Inc | 29.96 | $132.26M |
| RMD Resmed Inc | 30.22 | $28.95B |
| TMO Thermo Fisher Scientific Inc | 38.79 | $231.76B |
| MASI Masimo Corp | 72.66 | $5.79B |
| INGN Inogen Inc | N/A | $227.99M |
RMD's price to earnings ratio is 30.22 as of Jul 26, 2024.
As an average over the last 3 years, RMD stock has a PE ratio of 42.49.
As an average over the last 5 years, RMD stock has a PE ratio of 45.56.
Over the last ten years, the Sep 2021 quarter recorded the highest quarterly PE ratio at 76.39.
The current PE ratio of RMD is 21% lower than the 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jul 26, 2024), Resmed's share price is $197.04. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $6.52. Therefore, Resmed's PE ratio for today is 30.22. PE RATIO(30.22) = STOCK PRICE($197.04) / TTM EPS($6.52)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.